Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom, New England Biolabs Ink Deal for Epigenetics Technology

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – New England Biolabs and Sequenom said after the close of the market on Tuesday they have signed a licensing and co-marketing agreement for the commercialization of tools for epigenetics research.

They also announced the launch of the first product stemming from the research collaboration, which served as the basis for the agreement, the EpiMark Methylated DNA Enrichment Kit from NEB.

As part of the deal, NEB will be Sequenom's first supplier of choice if the technology is used for prenatal diagnostic purposes. Sequenom retains all rights for diagnostic uses.

Financial and other terms were not disclosed.

The kit uses technology and intellectual property, methyl-CpG-immunoprecipitation, that Sequenom acquired from the University of Regensburg, Germany. The technology is for the discovery and analysis of differentially methylated regions in biological samples, such as differences in methylation between fetal and maternal chromosomes that can be used for non-invasive prenatal diagnostics, the two companies said.

The kit incorporates the methyl-CpG binding domain of human MBD2, fused to the Fc tail of human IgG1. Coupled to magnetic beads, the protein enables purification of methylated CpG DNA with superior sensitivity, accuracy, and speed, NEB and Sequenom said.

Large scale, high purity manufacturing of the protein has been enabled and optimized by NEB, which developed its kit to be user-friendly for researchers.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.